Genmab reported DKK612M in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -98.58M 14.32M
AstraZeneca AZN:LN 3085M 1131M
Bluebird Bio BLUE:US $ -132.24M 84.69M
Genmab GEN:DC DK 612M 354M
GRIFOLS GRF:SM € 221M 44.67M
Immunogen IMGN:US $ -24.14M 13.03M
Novartis NOVN:VX SF 3682M 862M
William Demant Holding WDH:DC 1.71B 171M